Glossary GLP-1 Glucagon-like peptide-1 GLP-1R GLP-1 receptor GLP-1Ras GLP-1R agonists DPP4 Dipeptidyl peptidase 4 GRPP Glicentin-related pancreatic polypeptide cAMP Cyclic adenosine monophosphate T2DM Type 2 Diabetes Mellitus PKA Protein Kinase A RGNEF4 Rap Guanine Nucleotide Exchange Factor 4 IP3 Inositol triphosphate pathway DAG Diacylglycerol CNS Central Nervous System BBB Blood Brain Barrier AD Alzheimers Disease PD Parkinsons Disease ROS Reactive Oxygen Species BDNF Brain-Derived Neurotrophic factor LTP Long Term Potentiation Ex-4 Exendin-4 MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine CVOTs CV outcome trials CRP C-reactive protein SCALE Satiety and Clinical Adipose Liraglutide Evidence STEP Semaglutide Treatment Effect in People with Obesity BMI Body Mass Index VLDL Very low-density lipoprotein LDL Low-density lipoprotein ApoB48 Apolipoprotein B48 EAT Epicardial adipose tissue DPP-4i Dipeptidyl peptidase-4 inhibitors SGLT-2i Sodium-glucose cotransporter-2 inhibitor RGCs Retinal Ganglion Cells IOP Intraocular pressure DR Diabetic Retinopathy GDM Gestational Diabetes Mellitus PAI-1 Plasminogen activator inhibitor type 1 VAM Vascular adhesion molecule PCOS Polycystic ovarian syndrome FH Functional hypogonadism References 1 GraafCdDonnellyDWoottenDLauJSextonPMillerMet al

When does hair loss start
Read more on diabetes medications Use these evidence-based medication guides to move from the broad treatment overview into specific drug classes, side effects, and practical safety questions
The addition of the C-20 fatty acid moiety to Lys20 is hypothesized to increase the binding dose-response ratio due to an increased albumin affinity
Symptoms of B12 deficiency include exhaustion no matter how much you sleep, muscle weakness and frequent cramping, constipation, loss of appetite and unexplained weight loss, numbness or tingling in the hands and feet, depression, and problems with memory and focus